{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:10:57Z","timestamp":1791850257297,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s12033-025-01494-6","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T12:16:54Z","timestamp":1755260214000},"page":"2264-2284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["GALNT18-Mediated O-Glycosylation Promotes Development of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma Through Activation of EGR1\/TGF-\u03b21\/Smad Signaling"],"prefix":"10.1007","volume":"68","author":[{"given":"Dan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingfu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7890-8209","authenticated-orcid":false,"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"1494_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-024-00764-w","author":"F Safri","year":"2024","unstructured":"Safri, F., Nguyen, R., Zerehpooshnesfchi, S., George, J., & Qiao, L. (2024). Heterogeneity of hepatocellular carcinoma: From mechanisms to clinical implications. Cancer Gene Therapy. https:\/\/doi.org\/10.1038\/s41417-024-00764-w","journal-title":"Cancer Gene Therapy"},{"issue":"3","key":"1494_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229\u2013263.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"Suppl 1","key":"1494_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn, K. A., Petrick, J. L., & El-Serag, H. B. (2021). Epidemiology of hepatocellular carcinoma. Hepatology, 73(Suppl 1), 4\u201313.","journal-title":"Hepatology"},{"issue":"3","key":"1494_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"1494_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., et al. (2021). Hepatocellular carcinoma. Nature Reviews Disease Primers, 7(1), Article 6.","journal-title":"Nature Reviews Disease Primers"},{"issue":"7","key":"1494_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019). From NASH to HCC: Current concepts and future challenges. Nature Reviews Gastroenterology & Hepatology, 16(7), 411\u2013428.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"1","key":"1494_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","volume":"60","author":"J Dyson","year":"2014","unstructured":"Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., et al. (2014). Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team. Journal of Hepatology, 60(1), 110\u2013117.","journal-title":"Journal of Hepatology"},{"issue":"9","key":"1494_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/apt.14261","volume":"46","author":"R Pais","year":"2017","unstructured":"Pais, R., Fartoux, L., Goumard, C., Scatton, O., Wendum, D., Rosmorduc, O., & Ratziu, V. (2017). Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. Alimentary Pharmacology & Therapeutics, 46(9), 856\u2013863.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"1494_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., et al. (2018). Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. Journal of Hepatology, 69(4), 896\u2013904.","journal-title":"Journal of Hepatology"},{"issue":"4","key":"1494_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021). Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology and Hepatology, 18(4), 223\u2013238.","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"key":"1494_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108122","volume":"235","author":"Y Cho","year":"2022","unstructured":"Cho, Y., Bae, H. G., Okun, E., Arumugam, T. V., & Jo, D. G. (2022). Physiology and pharmacology of amyloid precursor protein. Pharmacology & Therapeutics, 235, Article 108122.","journal-title":"Pharmacology & Therapeutics"},{"key":"1494_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914794","author":"KS Orobets","year":"2023","unstructured":"Orobets, K. S., & Karamyshev, A. L. (2023). Amyloid precursor protein and Alzheimer\u2019s disease. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms241914794","journal-title":"International Journal of Molecular Sciences"},{"key":"1494_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094999","author":"HN Lee","year":"2021","unstructured":"Lee, H. N., Jeong, M. S., & Jang, S. B. (2021). Molecular characteristics of Amyloid Precursor Protein (APP) and its effects in cancer. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms22094999","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"1494_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1177\/1533034616661664","volume":"16","author":"L Zhao","year":"2017","unstructured":"Zhao, L., He, D., Jiao, M., Kong, L., Shao, C., Chen, J., et al. (2017). Overexpression of histone deacetylase and amyloid precursor protein in hepatocellular carcinoma. Technology in Cancer Research & Treatment, 16(5), 586\u2013594.","journal-title":"Technology in Cancer Research & Treatment"},{"issue":"3","key":"1494_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1631\/jzus.B1900413","volume":"21","author":"XL Wu","year":"2020","unstructured":"Wu, X. L., Chen, Y., Kong, W. C., & Zhao, Z. Q. (2020). Amyloid precursor protein regulates 5-fluorouracil resistance in human hepatocellular carcinoma cells by inhibiting the mitochondrial apoptotic pathway. Journal of Zhejiang University Science B, 21(3), 234\u2013245.","journal-title":"Journal of Zhejiang University Science B"},{"issue":"2","key":"1494_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/tox.23904","volume":"39","author":"Z Tao","year":"2024","unstructured":"Tao, Z., Huang, J., & Li, J. (2024). Comprehensive intratumoral heterogeneity landscaping of liver hepatocellular carcinoma and discerning of APLP2 in cancer progression. Environmental Toxicology, 39(2), 612\u2013625.","journal-title":"Environmental Toxicology"},{"issue":"2","key":"1494_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10719-016-9755-2","volume":"34","author":"BN Vajaria","year":"2017","unstructured":"Vajaria, B. N., & Patel, P. S. (2017). Glycosylation: A hallmark of cancer? Glycoconjugate Journal, 34(2), 147\u2013156.","journal-title":"Glycoconjugate Journal"},{"issue":"1","key":"1494_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/2211-5463.13308","volume":"12","author":"A Zayas-Santiago","year":"2022","unstructured":"Zayas-Santiago, A., Martinez-Montemayor, M. M., Colon-Vazquez, J., Ortiz-Soto, G., Cirino-Simonet, J. G., & Inyushin, M. (2022). Accumulation of amyloid beta (Abeta) and amyloid precursor protein (APP) in tumors formed by a mouse xenograft model of inflammatory breast cancer. FEBS Open Bio, 12(1), 95\u2013105.","journal-title":"FEBS Open Bio"},{"issue":"8","key":"1494_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/glycob\/cwab031","volume":"31","author":"W Jia","year":"2021","unstructured":"Jia, W., Zou, X., Xu, Z., Bai, L., Shan, A., Li, Y., et al. (2021). Polypeptide N-acetylgalactosaminyltransferase 18 retains in endoplasmic reticulum depending on its luminal regions interacting with ER resident UGGT1, PLOD3 and LPCAT1. Glycobiology, 31(8), 947\u2013958.","journal-title":"Glycobiology"},{"issue":"5","key":"1494_CR20","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bbagen.2019.01.009","volume":"1863","author":"A Shan","year":"2019","unstructured":"Shan, A., Lu, J., Xu, Z., Li, X., Xu, Y., Li, W., et al. (2019). Polypeptide N-acetylgalactosaminyltransferase 18 non-catalytically regulates the ER homeostasis and O-glycosylation. Biochimica et Biophysica Acta\u2014General Subjects, 1863(5), 870\u2013882.","journal-title":"Biochimica et Biophysica Acta\u2014General Subjects"},{"key":"1494_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111569","author":"K Akasaka-Manya","year":"2020","unstructured":"Akasaka-Manya, K., & Manya, H. (2020). The role of APP O-glycosylation in Alzheimer\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom10111569","journal-title":"Biomolecules"},{"issue":"52","key":"1494_CR22","doi-asserted-by":"publisher","first-page":"21304","DOI":"10.1074\/jbc.M117.814202","volume":"292","author":"F Liu","year":"2017","unstructured":"Liu, F., Xu, K., Xu, Z., de Las, R. M., Wang, C., Li, X., et al. (2017). The small molecule luteolin inhibits N-acetyl-alpha-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein. Journal of Biological Chemistry, 292(52), 21304\u201321319.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"1494_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JAD-140096","volume":"44","author":"YS Chun","year":"2015","unstructured":"Chun, Y. S., Park, Y., Oh, H. G., Kim, T. W., Yang, H. O., Park, M. K., & Chung, S. (2015). O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-beta protein precursor via inhibition of endocytosis from the plasma membrane. Journal of Alzheimer\u2019s Disease, 44(1), 261\u2013275.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"29","key":"1494_CR24","doi-asserted-by":"publisher","first-page":"11848","DOI":"10.1073\/pnas.1102664108","volume":"108","author":"A Halim","year":"2011","unstructured":"Halim, A., Brinkmalm, G., Ruetschi, U., Westman-Brinkmalm, A., Portelius, E., Zetterberg, H., et al. (2011). Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein\/amyloid beta-peptides in human cerebrospinal fluid. Proceedings of the National Academy of Sciences of the United States of America, 108(29), 11848\u201311853.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"28","key":"1494_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301166","volume":"10","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Zhang, Q., Teng, D., Guo, M., Tang, K., Wang, Z., et al. (2023). FGF9 recruits beta-catenin to increase hepatic ECM synthesis and promote NASH-driven HCC. Advanced Science, 10(28), Article e2301166.","journal-title":"Advanced Science"},{"issue":"1 Suppl","key":"1494_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","volume":"49","author":"D Scholten","year":"2015","unstructured":"Scholten, D., Trebicka, J., Liedtke, C., & Weiskirchen, R. (2015). The carbon tetrachloride model in mice. Laboratory Animals, 49(1 Suppl), 4\u201311.","journal-title":"Laboratory Animals"},{"issue":"5","key":"1494_CR27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.molcel.2020.03.030","volume":"78","author":"B Schumann","year":"2020","unstructured":"Schumann, B., Malaker, S. A., Wisnovsky, S. P., Debets, M. F., Agbay, A. J., Fernandez, D., et al. (2020). Bump-and-hole engineering identifies specific substrates of glycosyltransferases in living cells. Molecular Cell, 78(5), 824\u2013834.","journal-title":"Molecular Cell"},{"issue":"4","key":"1494_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25(4), 402\u2013408.","journal-title":"Methods"},{"issue":"10","key":"1494_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/glycob\/9.10.1009","volume":"9","author":"R Gupta","year":"1999","unstructured":"Gupta, R., Jung, E., Gooley, A. A., Williams, K. L., Brunak, S., & Hansen, J. (1999). Scanning the available Dictyostelium discoideum proteome for O-linked GlcNAc glycosylation sites using neural networks. Glycobiology, 9(10), 1009\u20131022.","journal-title":"Glycobiology"},{"issue":"7","key":"1494_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104905","volume":"299","author":"Y Tachida","year":"2023","unstructured":"Tachida, Y., Iijima, J., Takahashi, K., Suzuki, H., Kizuka, Y., Yamaguchi, Y., et al. (2023). O-GalNAc glycosylation determines intracellular trafficking of APP and Abeta production. Journal of Biological Chemistry, 299(7), Article 104905.","journal-title":"Journal of Biological Chemistry"},{"issue":"W1","key":"1494_CR31","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T., & Zhang, Z. (2019). GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research, 47(W1), W556\u2013W560.","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"1494_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100305","volume":"3","author":"ZM Younossi","year":"2021","unstructured":"Younossi, Z. M., & Henry, L. (2021). Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Reports, 3(4), Article 100305.","journal-title":"JHEP Reports"},{"issue":"1","key":"1494_CR33","doi-asserted-by":"publisher","first-page":"23056","DOI":"10.1038\/s41598-023-50328-5","volume":"13","author":"HH Hansen","year":"2023","unstructured":"Hansen, H. H., Pors, S., Andersen, M. W., Vyberg, M., Nohr-Meldgaard, J., Nielsen, M. H., et al. (2023). Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis. Scientific Reports, 13(1), 23056.","journal-title":"Scientific Reports"},{"issue":"12","key":"1494_CR34","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","volume":"4","author":"S Gallage","year":"2022","unstructured":"Gallage, S., Avila, J. E. B., Ramadori, P., Focaccia, E., Rahbari, M., Ali, A., et al. (2022). A researcher\u2019s guide to preclinical mouse NASH models. Nature Metabolism, 4(12), 1632\u20131649.","journal-title":"Nature Metabolism"},{"key":"1494_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000241","author":"N Ohtani","year":"2023","unstructured":"Ohtani, N., Kamiya, T., & Kawada, N. (2023). Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD\/NASH, HCC, and beyond. Hepatology Communications. https:\/\/doi.org\/10.1097\/HC9.0000000000000241","journal-title":"Hepatology Communications"},{"key":"1494_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223637","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., Li, Z., Xu, M., Zhang, D., Ling, J., Yu, P., & Shen, Y. (2022). O-glycnacylation remission retards the progression of non-alcoholic fatty liver disease. Cells. https:\/\/doi.org\/10.3390\/cells11223637","journal-title":"Cells"},{"issue":"6","key":"1494_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/glycob\/cwac009","volume":"32","author":"T Lin","year":"2022","unstructured":"Lin, T., van Husen, L. S., Yu, Y., Tjernberg, L. O., & Schedin-Weiss, S. (2022). Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein. Glycobiology, 32(6), 506\u2013517.","journal-title":"Glycobiology"},{"issue":"1","key":"1494_CR38","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1021\/acs.analchem.9b03555","volume":"92","author":"P Fang","year":"2020","unstructured":"Fang, P., Xie, J., Sang, S., Zhang, L., Liu, M., Yang, L., et al. (2020). Multilayered N-glycoproteome profiling reveals highly heterogeneous and dysregulated protein N-glycosylation related to Alzheimer\u2019s disease. Analytical Chemistry, 92(1), 867\u2013874.","journal-title":"Analytical Chemistry"},{"issue":"5","key":"1494_CR39","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1021\/acschemneuro.8b00574","volume":"10","author":"PF Tao","year":"2019","unstructured":"Tao, P. F., & Huang, H. C. (2019). Regulation of AbetaPP glycosylation modification and roles of glycosylation on AbetaPP cleavage in Alzheimer\u2019s disease. ACS Chemical Neuroscience, 10(5), 2115\u20132124.","journal-title":"ACS Chemical Neuroscience"},{"issue":"11","key":"1494_CR40","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cmet.2023.09.009","volume":"35","author":"P Zhou","year":"2023","unstructured":"Zhou, P., Chang, W. Y., Gong, D. A., Xia, J., Chen, W., Huang, L. Y., et al. (2023). High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate. Cell Metab, 35(11), 1961\u20131975.","journal-title":"Cell Metab"},{"issue":"12","key":"1494_CR41","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager, K. T., Narimatsu, Y., Joshi, H. J., & Clausen, H. (2020). Global view of human protein glycosylation pathways and functions. Nature Reviews Molecular Cell Biology, 21(12), 729\u2013749.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6","key":"1494_CR42","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/glycob\/cwr183","volume":"22","author":"J Raman","year":"2012","unstructured":"Raman, J., Guan, Y., Perrine, C. L., Gerken, T. A., & Tabak, L. A. (2012). UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferases: Completion of the family tree. Glycobiology, 22(6), 768\u2013777.","journal-title":"Glycobiology"},{"issue":"24","key":"1494_CR43","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41388-023-02702-w","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang, Y., & Chen, H. (2023). Protein glycosylation alterations in hepatocellular carcinoma: Function and clinical implications. Oncogene, 42(24), 1970\u20131979.","journal-title":"Oncogene"},{"issue":"1","key":"1494_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12967-024-05455-6","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Xu, W., Peng, C., Ren, S., & Zhang, C. (2024). Intricate effects of post-translational modifications in liver cancer: Mechanisms to clinical applications. Journal of Translational Medicine, 22(1), 651.","journal-title":"Journal of Translational Medicine"},{"key":"1494_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.665289","volume":"9","author":"X Zhang","year":"2021","unstructured":"Zhang, X. (2021). Alterations of golgi structural proteins and glycosylation defects in cancer. Frontiers in Cell and Developmental Biology, 9, Article 665289.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"1494_CR46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12672-025-02069-2","volume":"16","author":"TE Osman","year":"2025","unstructured":"Osman, T. E., Guo, Y., & Li, S. (2025). Exploring the combined roles of GALNT1 and GALNT2 in hepatocellular carcinoma malignancy and EGFR modulation. Discovery Oncology, 16(1), 337.","journal-title":"Discovery Oncology"},{"issue":"6","key":"1494_CR47","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1007\/s10565-023-09825-6","volume":"39","author":"X Dong","year":"2023","unstructured":"Dong, X., Leng, Y., Tian, T., Hu, Q., Chen, S., Liu, Y., & Shen, L. (2023). GALNT2, an O-glycosylating enzyme, is a critical regulator of radioresistance of non-small cell lung cancer: Evidence from an integrated multi-omics analysis. Cell Biology and Toxicology, 39(6), 3159\u20133174.","journal-title":"Cell Biology and Toxicology"},{"issue":"2","key":"1494_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ng1001-117","volume":"29","author":"R Derynck","year":"2001","unstructured":"Derynck, R., Akhurst, R. J., & Balmain, A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics, 29(2), 117\u2013129.","journal-title":"Nature Genetics"},{"issue":"11","key":"1494_CR49","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"M Pickup","year":"2013","unstructured":"Pickup, M., Novitskiy, S., & Moses, H. L. (2013). The roles of TGFbeta in the tumour microenvironment. Nature Reviews Cancer, 13(11), 788\u2013799.","journal-title":"Nature Reviews Cancer"},{"issue":"6","key":"1494_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/cancers10060183","volume":"10","author":"K Yoshida","year":"2018","unstructured":"Yoshida, K., Matsuzaki, K., Murata, M., Yamaguchi, T., Suwa, K., & Okazaki, K. (2018). Clinico-pathological importance of TGF-beta\/Phospho-Smad signaling during human hepatic fibrocarcinogenesis. Cancers (Basel), 10(6), 183.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1494_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.cgt.7700896","volume":"13","author":"V Baron","year":"2006","unstructured":"Baron, V., Adamson, E. D., Calogero, A., Ragona, G., & Mercola, D. (2006). The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Therapy, 13(2), 115\u2013124.","journal-title":"Cancer Gene Therapy"},{"key":"1494_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115922","author":"H Pavithran","year":"2023","unstructured":"Pavithran, H., Kumavath, R., & Ghosh, P. (2023). Transcriptome profiling of cardiac glycoside treatment reveals EGR1 and downstream proteins of MAPK\/ERK signaling pathway in human breast cancer cells. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms242115922","journal-title":"International Journal of Molecular Sciences"},{"key":"1494_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.biocel.2018.11.011","volume":"106","author":"JG Bi","year":"2019","unstructured":"Bi, J. G., Zheng, J. F., Li, Q., Bao, S. Y., Yu, X. F., Xu, P., & Liao, C. X. (2019). MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1\/TGF-beta\/Smad pathway in hepatocellular carcinoma. International Journal of Biochemistry & Cell Biology, 106, 107\u2013116.","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"1","key":"1494_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00664-9","volume":"12","author":"CP Boix","year":"2020","unstructured":"Boix, C. P., Lopez-Font, I., Cuchillo-Ibanez, I., & Saez-Valero, J. (2020). Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy, 12(1), Article 96.","journal-title":"Alzheimer's Research & Therapy"},{"issue":"4","key":"1494_CR55","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.7150\/ijbs.90598","volume":"20","author":"Y Jin","year":"2024","unstructured":"Jin, Y., Wang, C., Zhang, B., Sun, Y., Ji, J., Cai, Q., et al. (2024). Blocking EGR1\/TGF-beta1 and CD44s\/STAT3 crosstalk inhibits peritoneal metastasis of gastric cancer. International Journal of Biological Sciences, 20(4), 1314\u20131331.","journal-title":"International Journal of Biological Sciences"},{"key":"1494_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101559","author":"L Cui","year":"2022","unstructured":"Cui, L., Wang, X., Zhao, X., Sun, B., Xia, T., & Hu, S. (2022). CeO(2) nanoparticles induce pulmonary fibrosis via activating S1P pathway as revealed by metabolomics. Nano Today. https:\/\/doi.org\/10.1016\/j.nantod.2022.101559","journal-title":"Nano Today"},{"key":"1494_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020290","author":"GP Bacil","year":"2023","unstructured":"Bacil, G. P., Romualdo, G. R., Piagge, P., Cardoso, D. R., Vinken, M., Cogliati, B., & Barbisan, L. F. (2023). Unraveling hepatic metabolomic profiles and morphological outcomes in a hybrid model of NASH in different mouse strains. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12020290","journal-title":"Antioxidants"},{"issue":"1","key":"1494_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","volume":"29","author":"MA Febbraio","year":"2019","unstructured":"Febbraio, M. A., Reibe, S., Shalapour, S., Ooi, G. J., Watt, M. J., & Karin, M. (2019). Preclinical models for studying NASH-driven HCC: How useful are they? Cell Metabolism, 29(1), 18\u201326.","journal-title":"Cell Metabolism"},{"key":"1494_CR59","doi-asserted-by":"publisher","first-page":"1100285","DOI":"10.3389\/fmolb.2022.1100285","volume":"9","author":"Y Tang","year":"2022","unstructured":"Tang, Y., Guo, C., Chen, C., & Zhang, Y. (2022). Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma. Frontiers in Molecular Biosciences, 9, 1100285.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"3","key":"1494_CR60","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/HEP.0000000000000591","volume":"79","author":"M Li","year":"2024","unstructured":"Li, M., Wang, L., Cong, L., Wong, C. C., Zhang, X., Chen, H., et al. (2024). Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Hepatology, 79(3), 560\u2013574.","journal-title":"Hepatology"},{"issue":"37","key":"1494_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh0831","volume":"9","author":"E Boslem","year":"2023","unstructured":"Boslem, E., Reibe, S., Carlessi, R., Smeuninx, B., Tegegne, S., Egan, C. L., et al. (2023). Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC. Science Advances, 9(37), Article eadh0831.","journal-title":"Science Advances"},{"issue":"8","key":"1494_CR62","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1021\/acs.analchem.7b05215","volume":"90","author":"K Scupakova","year":"2018","unstructured":"Scupakova, K., Soons, Z., Ertaylan, G., Pierzchalski, K. A., Eijkel, G. B., Ellis, S. R., et al. (2018). Spatial systems lipidomics reveals nonalcoholic fatty liver disease heterogeneity. Analytical Chemistry, 90(8), 5130\u20135138.","journal-title":"Analytical Chemistry"},{"issue":"6","key":"1494_CR63","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1158\/2159-8290.CD-24-0174","volume":"14","author":"S Krieg","year":"2024","unstructured":"Krieg, S., Fernandes, S. I., Kolliopoulos, C., Liu, M., & Fendt, S. M. (2024). Metabolic signaling in cancer metastasis. Cancer Discovery, 14(6), 934\u2013952.","journal-title":"Cancer Discovery"},{"issue":"11","key":"1494_CR64","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4254\/wjh.v9.i11.533","volume":"9","author":"G Cholankeril","year":"2017","unstructured":"Cholankeril, G., Patel, R., Khurana, S., & Satapathy, S. K. (2017). Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World Journal of Hepatology, 9(11), 533\u2013543.","journal-title":"World Journal of Hepatology"},{"issue":"1","key":"1494_CR65","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/humrep\/dead228","volume":"39","author":"MJ Bayefsky","year":"2024","unstructured":"Bayefsky, M. J., Sampson, A., Blakemore, J. K., Jalili, D., Lilly, A. G., Fino, M. E., & Quinn, G. P. (2024). Experiences and intentions of patients undergoing medically indicated oocyte or embryo cryopreservation: A qualitative study. Human Reproduction, 39(1), 147\u2013153.","journal-title":"Human Reproduction"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-025-01494-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-025-01494-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-025-01494-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:02:45Z","timestamp":1779800565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-025-01494-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1007\/s12033-025-01494-6","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was granted by the Jinhua People\u2019s Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All patients provided written informed consent for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All animal experiments were approved by the Jinhua People\u2019s Hospital Ethics Committee and were conducted according to the local and international guidelines for animal welfare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal Participants"}}]}}